• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

ESCOP

CHOOSE YOUR ACCESSVIEWING DOWNLOAD

  • Home
  • About
    • Members
    • Directors
    • Scientific Committee
    • Supervising Editors
  • Monographs
    • Download
    • Online viewing
      • Subscription
    • 2nd Edition of the ESCOP Monographs: two volume
  • Testimonials
  • News
  • Publications
  • Contact us
  • Mailing List
  • Login
  • 0 items€0.00
You are here: Home / Downloads / Aloe barbadensis (Barbados Aloes)

Aloe barbadensis (Barbados Aloes)

January 5, 2015

Aloe barbadensis
Barbados Aloes
Aloe barbadensis Miller (Syn: Aloe vera (L.) Burm. f.)
Published 2014
Format: PDF

Checkout Added to cart

Online viewing (for only €30 per year, you can view online all the monographs)

 

 

SUMMARY:
The herbal monograph selects and summarises scientific studies regarding efficacy, dosage and safety to support the therapeutic uses of barbados aloes.
This herbal drug by definition consists of the concentrated and dried juice of the leaves of Aloe barbadensis Miller.
Studies with its main active and characteristic constituents barbaloin, which is a mixture of various aloins and aloe-emodin anthrone-C-glycosides, are included.
The therapeutic indication is, short term use of occasional constipation.
Administration of barbados aloes addresses: posology; its duration of use; contra-indications; special warnings; special precautions for use; interactions with other medicinal products; other forms of interaction; in pregnancy and lactation; its effects on ability to drive;  undesirable effects; especially regarding overdose.
Pharmacological studies concern pharmacokinetics of in vitro and in vivo experiments regarding the mechanism of action of barbados aloes, they also show anti-proliferative effects in cancer cell lines and assess absorption and secretion of barbados aloes and of islolated barbaloin, in animals and humans.
Preclinical safety data for barbados aloes were assessed in toxicity studies.
Safety data were assessed in human studies and suggest that this laxative should not be used for periods of more than 2 weeks, without medical advice.
The selection of literature cited in the monograph is aimed at bringing together relevant information about the possible physiological roles of barbados aloes and its major constituents.

KEYWORDS:

  • Aloe barbadensis Miller (Syn: Aloe vera (L.) Burm. f.)
  • Barbados Aloes
  • Constipation, for occasional short term use
Checkout Added to cart

Primary Sidebar

Join us

Subscribe to our Newsletter

Therapeutic indications (access to summaries and purchase)

  • Monograph (81)
    • Circulatory disorders (14)
      • Arterial hypertension (1)
      • Haemorrhoids (10)
        • Haemorrhoids (oral administration) (2)
        • Haemorrhoids (stools softener) (4)
        • Haemorrhoids (topical application) (4)
      • Microcirculatory disorders of the eye (1)
      • Mild cardiac complaints of nervous origin (1)
      • Peripheral vascular insufficiency (1)
      • Venous insufficiency (chronic) (5)
        • Varicose veins (oral administration) (3)
        • Varicose veins (topical administration) (2)
    • CNS disorders (7)
      • Depressive disorders (1)
      • Difficulty in falling asleep (1)
      • Exhaustion mental or physical (1)
      • Fatigue (1)
      • Headache (1)
      • Irritability (2)
      • Migraine prophylaxis (1)
      • Restlessness (3)
      • Tenseness (2)
    • Dermatological disorders (19)
      • Abrasions (2)
      • Acne (2)
      • Atopic dermatitis (1)
      • Bruises (4)
      • Cold sores (1)
      • Dermatitis (8)
      • Eczema (2)
      • Furuncles (1)
      • Herpes labialis (1)
      • Hyperhidrosis (1)
      • Insect bites (5)
      • Psoriasis (1)
      • Seborrhoea (2)
      • Skin inflammation (11)
      • Sunburn (1)
      • Wounds (7)
    • Digestive disorders (37)
      • Appetite loss (7)
      • Bloating (10)
      • Colitis (1)
      • Constipation habitual (3)
      • Constipation ocassional (6)
      • Diarrhoea (unspecific) (8)
      • Diverticulosis (1)
      • Dyspeptic complaints (16)
      • Enteritis (2)
      • Fissure anal (4)
      • Flatulence (10)
      • Gastritis (6)
      • Gastrointestinal complaints (6)
      • Heartburn (1)
      • Hepatobiliary disturbance (1)
      • Irritable bowel syndrome (3)
      • Spasmodic gastro-intestinal complaints (6)
    • Gynecological disorders (5)
      • Dysmenorrhoea (4)
      • Menopause (2)
      • Menorrhagia (1)
    • Metabolic disorders (4)
      • Diabetes (1)
      • Hypercholesterolaemia – Dyslipidaemia (4)
    • Mouth, ear, nose and throat disorders (18)
      • Anaesthetic dental (1)
      • Aphthous ulcers (3)
      • Dental healthcare: disinfectant mouthwash (1)
      • Gingivitis (5)
      • Inflammation of the oropharyngeal mucosa (13)
      • Pharyngitis (10)
      • Sore throat (2)
      • Stomatitis (10)
      • Tonsillitis (1)
    • Pain and inflammation (6)
      • Contusions (2)
      • Epicondylitis (1)
      • Low back pain (2)
      • Musculoskeletal inflammations (5)
      • Myalgia (2)
      • Osteoarthritis (3)
      • Periarthritis (2)
      • Rheumatic complaints (5)
      • Tendinitis (1)
    • Respiratory disorders (23)
      • Bronchitis (1)
      • Catarrh of the respiratory tract (14)
      • Common cold (12)
      • Cough (7)
      • Fever (3)
    • Urinary disorders (13)
      • Bacterial infections of the urinary tract (8)
      • Benign prostatic hyperplasia (2)
      • Cystitis (2)
      • Irrigation of the urinary tract (8)
      • Irritable bladder (1)
      • Urinary lithiasis (5)

Example of monograph

Psylli semen

Lists of monographs

  • List of monographs (online viewing)
  • List of monographs (download)

Privacy Policy and Disclaimer

Privacy Policy and Disclaimer

Are you looking to boost your knowledge?

Join us

Subscribe to our Newsletter

Members

AUSTRIA · GERMANY · HUNGARY · ITALY · NETHERLANDS · POLAND · PORTUGAL · SPAIN · SWITZERLAND · TURKEY · TURKEY · UNITED KINGDOM

Copyright © 1999-2022 ESCOP · Developed by Cita Publicaciones · Privacy Policy and Disclaimer